AMGN Earnings & Financial Statements
Amgen Inc.
$426.11
+$13.27(+3.21%)
65
Overall
80
Value
63
Tech
52
Quality
Market Cap
$223.19B
Volume
3.05M
52W Range
$288.00 - $447.03
Target Price
$403.61
AMGN earnings and financial statements: Amgen Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
AMGN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $36.75B | $33.42B | $28.19B | $26.32B | $25.98B |
| Cost of revenue | $12.04B | $12.86B | $8.45B | $6.41B | $6.45B |
| Operating income | $9.08B | $7.26B | $7.90B | $9.57B | $7.64B |
| EBITDA | $16.90B | $13.36B | $14.80B | $12.17B | $11.30B |
| Net income | $7.71B | $4.09B | $6.72B | $6.55B | $5.89B |
| EPS (diluted) | $14.23 | $7.56 | $12.49 | $12.11 | $10.28 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $90.59B | $91.84B | $97.15B | $65.12B | $61.16B |
| Total liabilities | $81.93B | $85.96B | $90.92B | $61.46B | $54.47B |
| Shareholders’ equity | $8.66B | $5.88B | $6.23B | $3.66B | $6.70B |
| Cash and equivalents | $9.13B | $11.97B | $10.94B | $7.63B | $7.99B |
| Long-term debt | $50.01B | $56.55B | $63.17B | $37.35B | $33.22B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $9.96B | $11.49B | $8.47B | $9.72B | $9.26B |
| Capital expenditure | -$1.86B | -$1.10B | -$1.11B | -$936.00M | -$880.00M |
| Free cash flow | $8.10B | $10.39B | $7.36B | $8.79B | $8.38B |
| Dividends paid | $5.12B | $4.83B | $4.56B | $4.20B | $4.01B |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMGN | $426.11 | +3.2% | 3.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |